Microbial and hypoxic cell DNA (null)

This entry, "Microbial and hypoxic cell DNA," encompasses the DNA present in both microbial cells and mammalian cells subjected to low oxygen environments. DNA in hypoxic cells experiences increased damage (e.g., oxidative base modifications, strand breaks) and mutations due to elevated reactive oxygen species and impaired DNA repair pathways. Hypoxia leads to transcriptional reprogramming through factors such as HIF binding to hypoxia response elements (HREs) within DNA, which modulate the expression of critical genes for adaptation, survival, and proliferation[2][3]. In cancer, hypoxic conditions promote genomic instability and resistance to DNA-damaging chemotherapeutics (e.g., cisplatin) due to frequent mutations and loss of DNA repair function (e.g., mismatch repair deficiency)[1]. In microbes, DNA adaptation to hypoxia may regulate key survival and metabolic genes, influencing pathogenicity and treatment targets[4][6]. However, "DNA" as such is not an actionable therapeutic target for drug development; drugs may target the processes acting *upon* DNA (such as repair pathways or hypoxia-regulated transcriptional machinery) rather than the DNA molecule itself. Note: This entry should be revised for specificity (e.g., referencing "Mismatch repair pathway" or "Hypoxia-inducible factor 1 alpha") to yield a therapeutically relevant target. As written, it describes a *category of biomolecules* rather than a distinct, targetable molecular entity.

Other names

DNA in microbesDNA in cells under hypoxia

DNA damage induction (by chemotherapeutics inducing crosslinks, strand breaks, and mutations); Modulation of gene expression through hypoxia-induced transcription factors, not direct DNA targeting